Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Sibanye-Stillwater
SBSW
$8.82B
| $5.47M | ﹤0.01% |
551,000
+288,500
| +110% | +$2.23M |
|
2827
ResMed
RMD
$34.5B
| $5.46M | ﹤0.01% |
+35,268
| New | +$5.08M |
|
2828
CALL
Nektar Therapeutics
NKTR
$2.47B
| $5.46M | ﹤0.01% |
16,867
-2,140
| -11% | -$621K |
|
2829
Agios Pharmaceuticals
AGIO
$2B
| $5.46M | ﹤0.01% |
114,344
-182,702
| -62% | -$6.91M |
|
2830
CALL
Cal-Maine
CALM
$3.8B
| $5.46M | ﹤0.01% |
127,700
-44,600
| -26% | -$1.86M |
|
2831
CALL
LiveRamp
RAMP
$2.29B
| $5.46M | ﹤0.01% |
113,500
-29,800
| -21% | -$1.34M |
|
2832
PUT
Fox Class A
FOXA
$28.8B
| $5.45M | ﹤0.01% |
147,100
-202,500
| -58% | -$6.93M |
|
|
CMD
2833
PUT
DELISTED
Cantel Medical Corporation
CMD
| $5.45M | ﹤0.01% |
76,900
+66,900
| +669% | +$4.85M |
|
2834
CALL
Insmed
INSM
$25.7B
| $5.45M | ﹤0.01% |
228,000
+92,700
| +69% | +$1.89M |
|
|
AXDX
2835
DELISTED
Accelerate Diagnostics
AXDX
| $5.44M | ﹤0.01% |
32,171
+5,601
| +21% | +$924K |
|
2836
eHealth
EHTH
$36.8M
| $5.43M | ﹤0.01% |
56,552
-40,052
| -41% | -$3.11M |
|
2837
PUT
EPR Properties
EPR
$4.58B
| $5.42M | ﹤0.01% |
76,800
+25,000
| +48% | +$1.84M |
|
2838
CALL
Amdocs
DOX
$6.61B
| $5.42M | ﹤0.01% |
75,100
-3,400
| -4% | -$232K |
|
2839
Euronet Worldwide
EEFT
$2.61B
| $5.41M | ﹤0.01% |
34,344
+5,498
| +19% | +$830K |
|
2840
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.8B
| $5.4M | ﹤0.01% |
46,700
-6,700
| -13% | -$744K |
|
2841
CALL
Saic
SAIC
$5.45B
| $5.4M | ﹤0.01% |
62,100
+16,800
| +37% | +$1.41M |
|
2842
CALL
Chemed
CHE
$6.85B
| $5.4M | ﹤0.01% |
12,300
+1,500
| +14% | +$631K |
|
2843
PUT
Zimmer Biomet
ZBH
$19B
| $5.4M | ﹤0.01% |
37,183
-17,201
| -32% | -$2.37M |
|
2844
CALL
Adient
ADNT
$1.46B
| $5.4M | ﹤0.01% |
254,200
-18,200
| -7% | -$404K |
|
|
LGF.A
2845
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $5.39M | ﹤0.01% |
505,856
-97,281
| -16% | -$896K |
|
2846
PUT
Ashland
ASH
$3.38B
| $5.39M | ﹤0.01% |
70,400
-1,100
| -2% | -$83.5K |
|
2847
Sonos
SONO
$1.83B
| $5.38M | ﹤0.01% |
344,350
+180,423
| +110% | +$2.51M |
|
2848
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.91B
| $5.37M | ﹤0.01% |
73,055
-20,750
| -22% | -$1.45M |
|
2849
PUT
Autohome
ATHM
$2.64B
| $5.37M | ﹤0.01% |
67,100
-42,200
| -39% | -$3.29M |
|
2850
CALL
SS&C Technologies
SSNC
$19.6B
| $5.37M | ﹤0.01% |
87,400
-106,700
| -55% | -$5.98M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.